{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:38:37Z","timestamp":1772480317197,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["Grant INV-038938"],"award-info":[{"award-number":["Grant INV-038938"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2020\/GNT1194248"],"award-info":[{"award-number":["2020\/GNT1194248"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008561","name":"Burnet Institute","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Risk screening tools can identify women at high-risk for developing pre-eclampsia, allowing for timely preventative care and monitoring. However, tools that are accurate, feasible and affordable for limited-resource settings are lacking. Target Product Profiles (TPPs) define the minimum and optimal criteria required for new products to achieve a specific health need. Through the Accelerating Innovation for Mothers (AIM) project, we developed the first TPP for pre-eclampsia risk screening tools, suitable for use in low- and middle-income countries (LMICs). We used a mixed-methods approach, including stakeholder interviews, an online multilingual survey, and public consultation to inform the draft TPP. Diverse stakeholders (e.g., clinicians, manufacturers, researchers) representing all WHO geographical regions were invited to participate. We used descriptive statistics to identify variables that met consensus (\u226575% agree or strongly agree) from surveys and qualitative content analysis to identify emerging themes from interviews. We conducted 26 interviews and received 84 survey responses, from diverse participants in terms of geographies, gender and country income level. Consensus was reached on all but two of the 25 TPP variables (tool recommendations, sample collection). Following interview feedback, we modified the TPP to include three distinct sections (biophysical, biochemical and digital), allowing these tool types to be clearly defined. This is the first TPP on risk screening tools for predicting pre-eclampsia. This will facilitate the development, evaluation and advancement of pre-eclampsia risk screening tools for pregnant women. It can help ensure these tools address real-world needs and current gaps in pre-eclampsia related care in LMICs.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005766","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:32:39Z","timestamp":1772476359000},"page":"e0005766","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expert consensus on pre-eclampsia risk screening tools for low- and middle-income countries: Development of a new Target Product Profile"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-6679","authenticated-orcid":true,"given":"Annie R. A.","family":"McDougall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahlia R.","family":"Guneratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Makama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Metin","family":"G\u00fclmezoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ammerdorffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Keir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile","family":"Ventola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-2719","authenticated-orcid":true,"given":"Jennifer","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Fern\u00e1ndez-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"7","key":"pgph.0005766.ref001","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, Challenges, and Perspectives","volume":"124","author":"S Rana","year":"2019","journal-title":"Circulation Research"},{"issue":"1","key":"pgph.0005766.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"E Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"pgph.0005766.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00560-6","article-title":"Global and regional causes of maternal deaths 2009-20: a WHO systematic analysis","volume":"13","author":"JA Cresswell","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pgph.0005766.ref004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"E Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"pgph.0005766.ref005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2020.01.008","article-title":"A review of omics approaches to study preeclampsia","volume":"92","author":"PA Benny","year":"2020","journal-title":"Placenta"},{"key":"pgph.0005766.ref006","volume-title":"Preeclampsia: pathogenesis","author":"S Karumanchi","year":"2023"},{"key":"pgph.0005766.ref007","unstructured":"WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. Geneva: World Health Organization. 2021."},{"key":"pgph.0005766.ref008","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management 2019 [Available from: https:\/\/www.nice.org.uk\/guidance\/ng133\/chapter\/Recommendations#management-of-pre-eclampsia"},{"key":"pgph.0005766.ref009","unstructured":"The American College of Obstetricians and Gynecologists. Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality 2021 [Available from: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/12\/low-dose-aspirin-use-for-the-prevention-of-preeclampsia-and-related-morbidity-and-mortality"},{"issue":"6","key":"pgph.0005766.ref010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"N O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"pgph.0005766.ref011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/uog.19019","article-title":"ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm","volume":"51","author":"LC Poon","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"pgph.0005766.ref012","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"N O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"pgph.0005766.ref013","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13\u2009weeks\u2019 gestation","volume":"52","author":"MY Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"pgph.0005766.ref014","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13\u2009weeks\u2019 gestation","volume":"52","author":"MY Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"pgph.0005766.ref015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/uog.27490","article-title":"Externally validated prediction models for pre-eclampsia: systematic review and meta-analysis","volume":"63","author":"SA Tiruneh","year":"2024","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"pgph.0005766.ref016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000779","article-title":"Not just a number: examining coverage and content of antenatal care in low-income and middle-income countries","volume":"3","author":"L Benova","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pgph.0005766.ref017","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1186\/s12884-022-05331-5","article-title":"Input, process, and output factors contributing to quality of antenatal care services: a scoping review of evidence","volume":"22","author":"RB Khatri","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"pgph.0005766.ref018","article-title":"Early antenatal care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013","volume":"5","author":"A-B Moller","year":"2017","journal-title":"Lancet Glob Health"},{"key":"pgph.0005766.ref019","unstructured":"Foundation C. Accelerating Innovation for Mothers: Target Product Profiles Geneva, Switzerland: Concept Foundation; 2021 [Available from: https:\/\/www.conceptfoundation.org\/accelerating-innovation-for-mothers\/target-product-profiles\/"},{"key":"pgph.0005766.ref020","unstructured":"Impact Global Health. Maternal Health Pipeline 2024 [Available from: https:\/\/www.policycuresresearch.org\/maternal-health-pipeline\/"},{"key":"pgph.0005766.ref021","unstructured":"Food and Drug Administration. Guidance for Industry and Review Staff Target Product Profile \u2014 A Strategic Development Process Tool (Draft Guidance). 2007."},{"key":"pgph.0005766.ref022","unstructured":"Target product profile for drugs to treat pre-eclampsia. Geneva: World Health Organization. 2023."},{"key":"pgph.0005766.ref023","unstructured":"Target product profile for drugs to prevent pre-eclampsia. World Health Organization. 2023."},{"issue":"11","key":"pgph.0005766.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001260","article-title":"Target product profiles for novel medicines to prevent and treat preeclampsia: An expert consensus","volume":"2","author":"AR Mcdougall","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"pgph.0005766.ref025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1471-0528.17314","article-title":"Expert consensus on novel medicines to prevent preterm birth and manage preterm labour: Target product profiles","volume":"131","author":"ARA McDougall","year":"2024","journal-title":"BJOG"},{"key":"pgph.0005766.ref026","unstructured":"Target product profile for drugs to prevent spontaneous preterm birth. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. [Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/0e680712-e983-4fbb-ab2f-39c8a939bb30\/content"},{"key":"pgph.0005766.ref027","unstructured":"Target product profile for drugs to manage preterm labour. Geneva: World Health Organization. 2023. Licence: CC BY-NC-SA 3.0 IGO. [Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/aaa67a08-1a13-46cd-84e0-69075f71e404\/content"},{"issue":"7","key":"pgph.0005766.ref028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321543","article-title":"Maternal gut microbiome interventions to improve maternal and perinatal health outcomes: Target product profile expert consensus and pipeline analysis","volume":"20","author":"K Mills","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"pgph.0005766.ref029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1471-0528.17314","article-title":"Expert consensus on novel medicines to prevent preterm birth and manage preterm labour: Target product profiles","volume":"131","author":"ARA McDougall","year":"2024","journal-title":"BJOG"},{"key":"pgph.0005766.ref030","unstructured":"Target Product Profile Directory: World Health Organisation; 2024 [Available from: https:\/\/www.who.int\/tools\/target-product-profile-database"},{"key":"pgph.0005766.ref031","unstructured":"QualtricsXM. USA. 2024 [Available from: https:\/\/www.qualtrics.com"},{"issue":"9","key":"pgph.0005766.ref032","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"H-F Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"pgph.0005766.ref033","unstructured":"PATH. Diagnostic Intrument - Target Product Profile: Hemoglobinometer. Version 1.1 - June 2018."},{"key":"pgph.0005766.ref034","unstructured":"World Health Organisation, Unicef, Pan American Health Organisation. Target Product Profiles fo better diagnostic tests for Zika Virus Infection. 13 April 2016."},{"key":"pgph.0005766.ref035","article-title":"Counting Every Drop: An expert consensus on novel Target Product Profiles for tools to measure blood loss at vaginal and caesarean births","author":"K Mills","year":"2025","journal-title":"Lancet O&G"},{"issue":"6","key":"pgph.0005766.ref036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000914","article-title":"How to implement new diagnostic products in low-resource settings: an end-to-end framework","volume":"3","author":"ML Mugambi","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"6","key":"pgph.0005766.ref037","doi-asserted-by":"crossref","first-page":"101882","DOI":"10.1016\/j.disamonth.2025.101882","article-title":"The integration of artificial intelligence into clinical medicine: Trends, challenges, and future directions","volume":"71","author":"PS Aravazhi","year":"2025","journal-title":"Dis Mon"},{"key":"pgph.0005766.ref038","doi-asserted-by":"crossref","first-page":"113899","DOI":"10.1016\/j.dss.2022.113899","article-title":"Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning","volume":"166","author":"B Wang","year":"2023","journal-title":"Decision Support Systems"},{"issue":"8","key":"pgph.0005766.ref039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027743","article-title":"Digital and online symptom checkers and health assessment\/triage services for urgent health problems: systematic review","volume":"9","author":"D Chambers","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"pgph.0005766.ref040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"EJ Topol","year":"2019","journal-title":"Nat Med"},{"key":"pgph.0005766.ref041","doi-asserted-by":"crossref","first-page":"880034","DOI":"10.3389\/fpubh.2022.880034","article-title":"On AI Approaches for Promoting Maternal and Neonatal Health in Low Resource Settings: A Review","volume":"10","author":"M Khan","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"pgph.0005766.ref042","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12911-025-02864-5","article-title":"Artificial intelligence-based risk assessment tools for sexual, reproductive and mental health: a systematic review","volume":"25","author":"S Islam","year":"2025","journal-title":"BMC Med Inform Decis Mak"},{"issue":"10","key":"pgph.0005766.ref043","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1373\/clinchem.2018.287052","article-title":"Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation","volume":"64","author":"P Wang","year":"2018","journal-title":"Clin Chem"},{"issue":"1","key":"pgph.0005766.ref044","doi-asserted-by":"crossref","DOI":"10.1007\/s44250-024-00163-w","article-title":"The role and impact of new technologies on healthcare systems","volume":"3","author":"R Sinha","year":"2024","journal-title":"Discov Health Systems"},{"issue":"4","key":"pgph.0005766.ref045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/14737159.2018.1460205","article-title":"The impact of digital technologies on point-of-care diagnostics in resource-limited settings","volume":"18","author":"N Gous","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"pgph.0005766.ref046","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015760","article-title":"Common evidence gaps in point-of-care diagnostic test evaluation: a review of horizon scan reports","volume":"7","author":"JY Verbakel","year":"2017","journal-title":"BMJ Open"},{"key":"pgph.0005766.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention","author":"LC Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"pgph.0005766.ref048","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management","volume":"44","author":"LA Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"pgph.0005766.ref049","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000132","article-title":"Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform","volume":"1","author":"N Engel","year":"2016","journal-title":"BMJ Glob Health"},{"key":"pgph.0005766.ref050","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for Industry - Q8(R2) Pharmaceutical Development. Maryland; USA, 2009."},{"issue":"9","key":"pgph.0005766.ref051","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17441692.2012.699088","article-title":"Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design","volume":"7","author":"A Brooks","year":"2012","journal-title":"Glob Public Health"},{"issue":"9","key":"pgph.0005766.ref052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237424","article-title":"Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus","volume":"15","author":"C Ferreyra","year":"2020","journal-title":"PLoS One"},{"key":"pgph.0005766.ref053","unstructured":"Target product profiles for tuberculosis diagnosis and detection of drug resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:32:48Z","timestamp":1772476368000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005766"}},"subtitle":[],"editor":[{"given":"Shiyam","family":"Sunder","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005766","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}